ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.

Magdalena Bieniasz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.